NASDAQ: DXCM
DexCom, Inc.
Healthcare · Medical - Devices
After hours: $73.22(+1.03%) · as of 7:53 PM ET
Market Cap
$27.96B
52w High
$89.98
52w Low
$54.11
P/E
30.66
Volume
7.63M
Outstanding Shares
385.87M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 10.54% over the last year. Revenue grew 16.15% over the trailing twelve months. Operating margin moved from 15.25% to 21.45%. Free cash flow grew 148.5% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 21.45%. A decisive move in revenue — currently up 16.15% — would be the clearest signal to resolve the ambiguity.
Company profile
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems.
Valuation
Stock splits
Every 1 shares became 4
Profitability & growth
Analyst consensus
42
Buy
8
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 29, 2026
Q3 FY26 · EPS est $0.60 · Revenue est $1.29B
View